Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters











Database
Language
Publication year range
1.
J Neuroimmunol ; 395: 578424, 2024 Oct 15.
Article in English | MEDLINE | ID: mdl-39128432

ABSTRACT

Neonatal immune activation (NIA) through exposure to lipopolysaccharide (LPS) induces adult behavioral changes in rodents that resemble symptoms of developmental disorders, such as autism spectrum disorder. The neonatal timing of LPS exposure appears to play a crucial role in determining the nature and extent of long-term changes. This study aims to explore whether a 3-day LPS-NIA triggers sex- and age-related changes in gut function, potentially linking LPS-NIA to gastrointestinal dysfunction. Male and female Swiss mice received intraperitoneal injections of LPS or saline on postnatal days (PN) 3, 5, and 7. At PN35 (juvenile) and PN70 (adult), gut inflammation and oxidative stress were evaluated in addition to assessments of working memory, depressive-like symptoms, sociability, and repetitive behavior. Gut examination showed elevated C-X-C motif chemokine receptor 3 (CXCR3) in LPS-NIA mice, while MyD88 and Zonulin expressions were significantly higher only in adult LPS-NIA females. Interleukin (IL)-23 expression increased in juvenile and adult male and juvenile female LPS-NIA mice. Oxidative changes included decreased duodenal reduced glutathione (GSH) in juvenile females and ileal GSH in adult females exposed to LPS-NIA. Regarding behavioral alterations, adult LPS-NIA females exhibited depressive-like behavior. Working memory deficits were observed across all LPS-NIA groups. Only juvenile LPS-NIA females increased grooming, while rearing was higher in adult LPS-NIA mice of both sexes. The findings imply that LPS-NIA impacts intestinal barrier function and causes gut inflammatory alterations that are sex- and age-specific. These findings pave the way for exploring potential mechanisms that could contribute to LPS-induced gastrointestinal disturbances among individuals with ASD.


Subject(s)
Animals, Newborn , Lipopolysaccharides , Sex Characteristics , Animals , Lipopolysaccharides/toxicity , Female , Mice , Male , Age Factors , Oxidative Stress/drug effects , Oxidative Stress/physiology , Aging/immunology , Aging/physiology
2.
Nutr Res ; 125: 1-15, 2024 May.
Article in English | MEDLINE | ID: mdl-38428258

ABSTRACT

Açaí seed extract (ASE) is obtained from Euterpe oleracea Mart. (açaí) plant (Amazon region) has high nutritional and functional value. ASE is rich in polyphenolic compounds, mainly proanthocyanidins. Proanthocyanidins can modulate the immune system and oxidative stress by inhibiting the toll-like receptor-4 (TLR-4)/myeloid differentiation primary response 88 (MyD88)/nuclear factor-κB (NF-κB) pathway. A great deal of evidence suggests that inflammatory cytokines and oxidative stress contribute to the pathogenesis of intestinal mucositis, and these events can lead to intestinal dysmotility. We hypothesized that ASE acts as an anti-inflammatory and antioxidant compound in intestinal mucositis induced by 5-fluorouracil (5-FU) through modulation of the TLR-4/MyD88/phosphatidylinositol-3-kinase α/mechanistic target of rapamycin/NF-κBp65 pathway. The animals were divided into linear 5-FU (450 mg/kg) and 5-FU + ASE (10, 30, and 100 mg/kg) groups. The weight loss of the animals was evaluated daily. Samples from duodenum, jejunum, and ileum were obtained for histopathological, biochemical, and functional analyses. ASE reduced weight loss, inflammatory parameters (interleukin-1ß; tumor necrosis factor-α; myeloperoxidase activity) and the gene expression of mediators involved in the TLR-2/MyD88/NF-κB pathway. ASE prevented histopathological changes with beneficial effects on gastrointestinal transit delay, gastric emptying, and intestinal absorption/permeability. In conclusion, ASE protects the integrity of the intestinal epithelial barrier by inhibiting the TLR/MyD88/PI3K/mechanistic target of rapamycin/NF-κBp65 pathway.


Subject(s)
Euterpe , Fluorouracil , Mucositis , Myeloid Differentiation Factor 88 , Plant Extracts , Polyphenols , Seeds , Signal Transduction , TOR Serine-Threonine Kinases , Toll-Like Receptor 4 , Animals , Toll-Like Receptor 4/metabolism , Mucositis/chemically induced , Mucositis/drug therapy , Mucositis/prevention & control , Mucositis/metabolism , Myeloid Differentiation Factor 88/metabolism , TOR Serine-Threonine Kinases/metabolism , Signal Transduction/drug effects , Plant Extracts/pharmacology , Seeds/chemistry , Polyphenols/pharmacology , Male , Euterpe/chemistry , Mice , Intestinal Mucosa/drug effects , Intestinal Mucosa/metabolism , Transcription Factor RelA/metabolism , Antioxidants/pharmacology , Phosphatidylinositol 3-Kinases/metabolism , Oxidative Stress/drug effects , Anti-Inflammatory Agents/pharmacology , NF-kappa B/metabolism
3.
Naunyn Schmiedebergs Arch Pharmacol ; 397(8): 6017-6035, 2024 08.
Article in English | MEDLINE | ID: mdl-38386042

ABSTRACT

Mania is associated with disturbed dopaminergic transmission in frontotemporal regions. D-amphetamine (AMPH) causes increased extracellular DA levels, considered an acknowledged mania model in rodents. Doxycycline (DOXY) is a second-generation tetracycline with promising neuroprotective properties. Here, we tested the hypothesis that DOXY alone or combined with Lithium (Li) could reverse AMPH-induced mania-like behavioral alterations in mice by the modulation of monoamine levels in brain areas related to mood regulation, as well as cytoprotective and antioxidant effects in hippocampal neurons. Male Swiss mice received AMPH or saline intraperitoneal (IP) injections for 14 days. Between days 8-14, mice receive further IP doses of DOXY, Li, or their combination. For in vitro studies, we exposed hippocampal neurons to DOXY in the presence or absence of AMPH. DOXY alone or combined with Li reversed AMPH-induced risk-taking behavior and hyperlocomotion. DOXY also reversed AMPH-induced hippocampal and striatal hyperdopaminergia. In AMPH-exposed hippocampal neurons, DOXY alone and combined with Li presented cytoprotective and antioxidant effects, while DOXY+Li also increased the expression of phospho-Ser133-CREB. Our results add novel evidence for DOXY's ability to reverse mania-like features while revealing that antidopaminergic activity in some brain areas, such as the hippocampus and striatum, as well as hippocampal cytoprotective effects may account for this drug's antimanic action. This study provides additional rationale for designing clinical trials investigating its potential as a mood stabilizer agent.


Subject(s)
Antioxidants , Doxycycline , Hippocampus , Mania , Neurons , Animals , Male , Neurons/drug effects , Neurons/metabolism , Hippocampus/drug effects , Hippocampus/metabolism , Mice , Antioxidants/pharmacology , Mania/chemically induced , Mania/drug therapy , Doxycycline/pharmacology , Behavior, Animal/drug effects , Cells, Cultured , Amphetamine/pharmacology , Amphetamine/toxicity , Disease Models, Animal , Central Nervous System Stimulants/toxicity , Biogenic Monoamines/metabolism , Dextroamphetamine/pharmacology , Dextroamphetamine/toxicity , Antimanic Agents/pharmacology , Neuroprotective Agents/pharmacology
4.
Inflammopharmacology ; 29(1): 193-204, 2021 Feb.
Article in English | MEDLINE | ID: mdl-32996043

ABSTRACT

Euterpe oleracea Mart., commonly known as açaí, has been demonstrated to exhibit significantly antioxidant and inflammatory activities in experimental models. These effects of the hydroalcoholic extract from the açaí seed (ASE) were investigated in TNBS-induced (2,4,6-trinitrobenzenesulfonic acid) acute colitis model in rats. Wistar rats (180-220 g) were orally pretreated with saline (0.3 mL), ASE (10, 30 and 100 mg/kg) and dexamethasone (control group, 1 mg/kg) once daily for 3 days starting before TNBS instillation. On day 3 after TNBS, the animals were euthanized, the portion of distal colon was collected and washed with 0.9% saline for macroscopy and histological evaluation, glutathione (GSH) and malonyldialdehyde (MDA) levels, myeloperoxidase (MPO) and catalase (CAT) activity, nitrate and nitrite (NO3/NO2) concentration, pro-inflammatory cytokines levels and intestinal barrier integrity. We also evaluated Toll-like Receptor 4/cyclooxygenase-2/nuclear factor kappa B expression as a possible mechanism related to the ASE effects. Treatment with ASE 100 mg/kg decreased significantly macroscopic and microscopic damage induced by TNBS. In addition, MPO activity, TNF-α (tumor necrosis factor-alpha) and IL-1ß (interleukin 1) levels were reduced in rats with colitis. ASE 100 mg/kg restored GSH and MDA levels, CAT activity, NO3/NO2 concentration and improved the intestinal barrier integrity in the TNBS group. ASE 100 mg/kg significantly reduced TNBS-induced expression of the TLR4, COX-2 and NF-κB p65. ASE 100 mg/kg improved macroscopy and histological parameters, inflammation, intestinal barrier integrity and nitric and oxidative stress through the TLR-4/COX-2/NF-κB pathway.


Subject(s)
Colitis/drug therapy , Euterpe/chemistry , Inflammation/drug therapy , Plant Extracts/pharmacology , Animals , Antioxidants/administration & dosage , Antioxidants/isolation & purification , Antioxidants/pharmacology , Colitis/physiopathology , Cyclooxygenase 2/metabolism , Disease Models, Animal , Dose-Response Relationship, Drug , Inflammation/physiopathology , Male , NF-kappa B/metabolism , Oxidative Stress/drug effects , Plant Extracts/administration & dosage , Rats , Rats, Wistar , Toll-Like Receptor 4/metabolism , Trinitrobenzenesulfonic Acid
SELECTION OF CITATIONS
SEARCH DETAIL